Category
Blog
-
2023
-
Pfizer’s BLA for Its RSV Vaccine Gets Priority Review
-
Ifenprodil for IPF Earns Orphan Drug Designation
-
Olutasidenib Gains FDA Approval for IDH1-Mutated Relapsed/Refractory Acute Myeloid Leukemia
-
EU Approves Takeda’s Dengue Vaccine
-
Istesso’s Idiopathic Pulmonary Fibrosis Candidate Gains Fast Track
-
SABCS: Pharmas show their working in HR+/HER2- breast cancer
-
The Effect of Aging in Multiple Sclerosis and the Model of Care
-
Moleculin Biotech’s WP1122 Receives Fast Track Status for Glioblastoma
-
ASH: CD20 bispecific antibodies take centre stage in lymphoma
-
British Pharma Industry Cites Six Companies for Code Violations